Navigation Links
Scientists publish analysis of algae parasite impact on algae biofuel in PLOS ONE
Date:2/20/2013

SAN DIEGO, February 20, 2013 As part of an ongoing effort to improve commercial scale algae biofuel production, a group of scientists, led by crude oil producer Sapphire Energy, Inc., today announced the completion of a collaborative study which identified the morphology, ultrastructure, and life history of A. protococcarum, one of the most difficult to manage algae parasites. Their findings are detailed in "Characterization of Amoeboaphelidium protococcarum: An Algal Parasite New to the Cryptomycota Isolated from an Outdoor Algal Pond Used for the Production of Biofuel," published today in the online scientific journal PLOS ONE. The article provides a comprehensive study of the parasite challenge facing crop protection for scaled algae cultivation in open-pond systems. These results will provide a broader understanding and promote the development of sustainable management strategies for biofuel production.

This article was prepared in collaboration by Robert C. McBride, Ph.D., Salvador Lopez, MSc, Craig Behnke, Ph.D., and Philip A. Lee, Ph.D., of Sapphire Energy; Peter M. Letcher, Ph.D., and Martha J. Powell, Ph.D., of the Department of Biological Sciences at the University of Alabama; and Robert Schmieder, Ph.D., of the Department of Computer Science and Computational Science Research Center at San Diego State University.

"Identifying and overcoming crop protection challenges, from pest control to environmental factors, is critical to ensuring successful, scalable algae farming, and has long been a part of the research and development objective of Sapphire Energy," said Alex Aravanis, MD, Ph.D., chief science officer at Sapphire Energy. "This collaborative study demonstrates the power of synergy when academic and industrial scientists work together for a common goal, and lays the groundwork for the better understanding and creation of innovative strategies that will facilitate algae biofuel production at commercial scale."


'/>"/>

Contact: Beth Llewelyn
beth@zebrapartners.net
206-406-5027
Zebra Partners
Source:Eurekalert

Related biology news :

1. UCLA scientists develop new therapeutics that could accelerate wound healing
2. Insects scientists and children meeting in Las Cruces, New Mexico
3. Brown University scientists to discuss resilience of coastal communities at AAAS
4. Going negative: Stanford scientists explore new technologies that remove atmospheric CO2
5. Biodiversity protects against disease, scientists find
6. Scientists develop improved fire management tools for Africas savannas
7. NTU Provost receives prestigious Imperial College fellowship joining the ranks of top UK scientists
8. Southern insect scientists to meet in Baton Rouge in March
9. Scientists discover how animals taste, and avoid, high salt concentrations
10. Mainz scientists confirm original tetrahedral model of the molecular structure of water
11. Got to go? Harvard scientists figure out how you know
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Research and Markets has announced the addition ... to their offering. ... The global voice recognition biometrics market to grow at a ... report covers the present scenario and the growth prospects of the ... size, the report considers the revenue generated from the sales of ...
(Date:1/18/2017)... -- In vitro diagnostic (IVD) companies were very active in ... Kalorama Information expects that trend to continue – though ... uncertainty in reimbursement and healthcare reform in ... acquisitions landscape. Instead of looking to buy technology, the ... of their home country and also to increase their ...
(Date:1/12/2017)... SAN DIEGO , Jan. 12, 2017  Trovagene, ... circulating tumor DNA (ctDNA) technologies, today announced that it ... Europe and the Middle ... biopsy tests.  This milestone marks the first wave of ... tests for urine and blood samples. The ...
Breaking Biology News(10 mins):
(Date:2/15/2017)... 2017  Trianni, Inc. („TRIANNI") gab heute bekannt, ... Lizenzvereinbarung über die Verwendung der The Trianni Mouse ... die Entdeckung monoklonaler Antikörper. Die Trianni ... aus, das Janssen den Zugang zu ... das für die schelle Isolierung vollständig menschlicher Therapeutika ...
(Date:2/15/2017)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced ... and full year ended December 31, 2016. ... as we continued to demonstrate strong growth in ... Fanapt," said Mihael H. Polymeropoulos, M.D., Vanda,s President ... important 2017 milestones underscores Vanda,s commitment to bringing ...
(Date:2/15/2017)... Feb. 15, 2017 Windtree Therapeutics, Inc. (Nasdaq: ... developing aerosolized KL4 surfactant therapies for respiratory diseases, will ... presentation) at 8:00 AM EST on Thursday, February 16, ... clinical program, the recently announced closing of a $10.5 ... To participate in the live call and ...
(Date:2/15/2017)... ... February 15, 2017 , ... Diameter Health (Diameter) ... Health technology in the hands of Lantana analysts. The high-performance platform of Diameter ... public health entities – all those mining value from clinical data – to ...
Breaking Biology Technology: